PROPOSED ACTION ON REGULATIONS
MARYLAND REGISTER, VOLUME 41, ISSUE 14,
FRIDAY, JULY 11, 2014
Title 09 DEPARTMENT OF LABOR, LICENSING, AND REGULATION
Subtitle 10 RACING COMMISSION
09.10.03 Prohibited Acts
Authority: Business Regulation Article, §11-210, Annotated Code of Maryland
Notice of Proposed Action
The Maryland Racing Commission proposes to amend Regulation .01-1 under
COMAR 09.10.03 Prohibited Acts. This action was considered by the Maryland Racing Commission at a public meeting held on May 20, 2014,
notice of which was given by publication in 41:9 Md. R. 542 (May 2, 2014), in accordance with State Government Article, §10-506(c), Annotated Code of
Statement of Purpose
The purpose of this action is to add two therapeutic medications to the current list of 24 permissive medications and to lower the permitted
Comparison to Federal Standards
There is no corresponding federal standard to this proposed action.
Estimate of Economic Impact
The proposed action has no economic impact.
Economic Impact on Small Businesses
The proposed action has minimal or no economic impact on small businesses.
Impact on Individuals with Disabilities
The proposed action has no impact on individuals with disabilities.
Opportunity for Public Comment
Comments may be sent to J. Michael Hopkins, Executive Director, Maryland Racing Commission, 300 East Towsontown Blvd. Towson, MD 21286, or
call 410-296-9682, or email to email@example.com, or fax to 410-296-9687. Comments
will be accepted through August 15, 2014. A public hearing has not been scheduled.
Final action on the proposal will be considered by the Maryland Racing Commission during a public meeting to be held on August 19, 2014, at
12:30 p.m. at Ocean Downs Raceway, Berlin, Maryland.
.01-1 Restricted Use of Medications and Other Substances.
The use of the following medications and other substances are permitted if quantitated at not more than the specified thresholds:
A. (text unchanged)
A-1. Albuterol quantitated at not more than 1 nanogram per milliliter of urine;
B.— N. (text unchanged)
N-1. Isoflupredone quantitated at not more than 100 picograms per milliliter of blood plasma or serum;
O. Ketoprofen quantitated at not more than  2 nanograms per milliliter of blood plasma or serum;
P. —Y. (text unchanged)
[Z. Stanozolol quantitated at not more than 1 nanogram per milliliter of urine;]
[AA.] Z. — [DD.] CC. (text unchanged)
J. MICHAEL HOPKINS